Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin and Mirabegron in Children With Overactive Bladder and Daytime Urinary Incontinence
NCT06551246Phase 3Recruiting
- Sponsor
- Aarhus University
- Start
- Jun 2024
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of solifenacin, mirabegron in overactive bladder (OAB), urinary incontinence (UI), sponsored by Aarhus University. Started Jun 2024; status: recruiting.
02
Drugs
solifenacinmirabegron
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT06551246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06551246.